While side effects are generally mild and temporary, they may include redness or soreness at the injection site, a temporary "flushed" feeling, or brief lightheadedness
through body weight loss and improvement of body composition, has the potential to reduce the risk of heart disease, diabetes, and stroke in people with overweight or obesity, according to the lead researcher
The breadth of data was presented during a late-breaking symposium at the 2026 Scientific Sessions of the American Diabetes Association (ADA) in New Orleans, June 58, alongside the simultaneous publication of REIMAGINE 1 and 2 trial results in The Lancet Diabetes & Endocrinology and the REIMAGINE 3 trial results in The Lancet
My vision no longer goes black
So long as the brand-name options remain pricy, theres incentive for 503As to create these slightly changed versions
What If I'm Already on a GLP-1 Medication for Diabetes Should I Expect GERD Improvement